At a glance
ClinicalIndex Comparison RecordN/ACompleted· 201 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 4, Open Label, Study of Safety and Effectiveness of GRALISE™(Gabapentin) Tablets in the Treatment of Patients With Postherpetic Neuralgia in Clinical Practice
In Brief
An observational study for Post Herpetic Neuralgia. Completed, enrolled 201 participants across 37 sites.
Detailed Summary
Study objective is to assess the safety and effectiveness of once- daily GRALISE in clinical practice
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPost Herpetic Neuralgia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedAug 2011
Enrollment StartSep 2011
Primary CompletionMar 2012
Study CompletionApr 2012
TodayJul 2026
First PostedAug 31, 2011
Enrollment StartSep 1, 2011
Primary CompletionMar 1, 2012
Study CompletionApr 1, 2012
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 14.8 years ago